Iridex (IRIX) Net Cash Flow Growth (5y) (2016 - 2026)
Iridex (IRIX) Net Cash Flow Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Iridex | 13.34 Mn | 8.66 Mn | 4.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -15.86% |
| Sep 27, 2025 | -38.90% |
| Jun 28, 2025 | -23.31% |
| Mar 29, 2025 | 39.08% |
| Dec 28, 2024 | -41.31% |
| Sep 28, 2024 | 38.03% |
| Jun 29, 2024 | 2.68% |
| Mar 30, 2024 | 16.44% |
| Dec 30, 2023 | 17.53% |
| Sep 30, 2023 | -17.59% |
| Jul 1, 2023 | 13.33% |
| Apr 1, 2023 | 2.35% |
| Dec 31, 2022 | -9.89% |
| Oct 1, 2022 | -3.50% |
| Jul 2, 2022 | -41.77% |
| Apr 2, 2022 | -99.35% |
| Jan 1, 2022 | -2.06% |
| Apr 3, 2021 | 99.26% |
| Mar 28, 2020 | -53.11% |
| Sep 28, 2019 | -76.76% |